$ATOM
Atomera Inc Stock $atom

$atom Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000168316823000938 Filed on February 15, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$0.00	$5.000K	$382.0K
YoY Change	-100.0%		-4.5%
Cost Of Revenue	$0.00	$0.00	$81.00K
YoY Change	-100.0%
Gross Profit	$0.00	$5.000K	$301.0K
YoY Change	-100.0%		-24.75%
Gross Profit Margin		100.0%	78.8%
Selling, General & Admin	$2.131M	$1.888M	$7.789M
YoY Change	8.01%	3.51%	8.94%
% of Gross Profit		37760.0%	2587.71%
Research & Development	$3.036M	$2.523M	$10.04M
YoY Change	29.8%	12.18%	14.34%
% of Gross Profit		50460.0%	3334.88%
Depreciation & Amortization	$20.00K	$310.0K	$77.00K
YoY Change	0.0%	1450.0%	14.93%
% of Gross Profit		6200.0%	25.58%
Operating Expenses	$5.167M	$4.411M	$17.83M
YoY Change	19.83%	8.3%	11.92%
Operating Profit	-$5.167M	-$4.406M	-$17.53M
YoY Change	28.6%	8.18%	12.86%
Interest Expense	$53.00K	$134.0K	$255.0K
YoY Change	-177.94%	-281.08%	-314.29%
% of Operating Profit
Other Income/Expense, Net	$148.0K		$85.00K
YoY Change	-317.65%		-171.43%
Pretax Income	-$5.019M	-$4.272M	-$17.44M
YoY Change	22.83%	3.01%	11.46%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.019M	-$4.272M	-$17.44M
YoY Change	22.83%	2.57%	10.99%
Net Earnings / Revenue		-85440.0%	-4565.71%
Basic Earnings Per Share	-$0.21		-$0.75
Diluted Earnings Per Share	-$0.21	-$0.18	-$0.75
COMMON SHARES
Basic Shares Outstanding	23.97M shares	23.85M shares	23.16M shares
Diluted Shares Outstanding	23.66M shares		23.16M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.05M	$21.18M	$21.18M
YoY Change	-30.26%	-26.19%	-26.19%
Cash & Equivalents	$12.12M	$21.18M	$21.18M
Short-Term Investments	$4.934M
Other Short-Term Assets	$303.0K	$418.0K	$418.0K
YoY Change	-64.18%	35.28%	35.28%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$17.36M	$21.60M	$21.60M
YoY Change	-32.2%	-25.53%	-25.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$153.0K	$158.0K	$5.022M
YoY Change	-97.67%	-19.39%	-27.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$105.0K	$105.0K	$105.0K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$4.780M	$5.127M	$5.127M
YoY Change	-28.43%	-27.3%	-27.3%
TOTAL ASSETS
Total Short-Term Assets	$17.36M	$21.60M	$21.60M
Total Long-Term Assets	$4.780M	$5.127M	$5.127M
Total Assets	$22.14M	$26.73M	$26.73M
YoY Change	-31.42%	-25.88%	-25.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$423.0K	$397.0K	$397.0K
YoY Change	11.32%	17.46%	17.46%
Accrued Expenses	$242.0K	$173.0K	$1.385M
YoY Change	-66.3%	-14.78%	35.78%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.240M	$1.126M	$1.126M
YoY Change	-11.17%	-19.28%	-19.28%
Total Short-Term Liabilities	$2.444M	$2.908M	$2.908M
YoY Change	-2.0%	5.63%	5.63%
LONG-TERM LIABILITIES
Long-Term Debt	$2.683M	$2.986M	$2.986M
YoY Change	-30.67%	-28.19%	-28.19%
Other Long-Term Liabilities	$475.0K	$521.0K	$521.0K
YoY Change	-34.48%	-32.16%	-32.16%
Total Long-Term Liabilities	$3.158M	$3.507M	$3.507M
YoY Change	-31.27%	-28.81%	-28.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.444M	$2.908M	$2.908M
Total Long-Term Liabilities	$3.158M	$3.507M	$3.507M
Total Liabilities	$5.602M	$6.415M	$6.415M
YoY Change	-20.98%	-16.46%	-16.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$188.3M	-$183.3M
YoY Change		10.52%
Common Stock	$204.8M	$203.6M
YoY Change		4.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.53M	$20.31M	$20.31M
YoY Change
Total Liabilities & Shareholders Equity	$22.14M	$26.73M	$26.73M
YoY Change	-31.42%	-25.88%	-25.88%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$5.019M	-$4.272M	-$17.44M
YoY Change	22.83%	2.57%	10.99%
Depreciation, Depletion And Amortization	$20.00K	$310.0K	$77.00K
YoY Change	0.0%	1450.0%	14.93%
Cash From Operating Activities	-$4.234M	-$2.918M	-$12.50M
YoY Change	2.99%	-3.92%	0.47%
INVESTING ACTIVITIES
Capital Expenditures	$15.00K	$13.00K	$39.00K
YoY Change	-193.75%	-285.71%	-135.78%
Acquisitions
YoY Change
Other Investing Activities	-$4.942M
YoY Change
Cash From Investing Activities	-$4.957M	-$13.00K	-$39.00K
YoY Change	30881.25%	85.71%	-64.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$125.0K	828.0K	$5.023M
YoY Change	-203.31%	-1900.0%	51.89%
NET CHANGE
Cash From Operating Activities	-$4.234M	-2.918M	-$12.50M
Cash From Investing Activities	-$4.957M	-13.00K	-$39.00K
Cash From Financing Activities	$125.0K	828.0K	$5.023M
Net Change In Cash	-$9.066M	-2.103M	-$7.515M
YoY Change	113.42%	-31.94%	-18.7%
FREE CASH FLOW
Cash From Operating Activities	-$4.234M	-$2.918M	-$12.50M
Capital Expenditures	$15.00K	$13.00K	$39.00K
Free Cash Flow	-$4.249M	-$2.931M	-$12.54M
YoY Change	3.76%	-3.27%	1.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001420520
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-37850
CY2022	dei	Entity Registrant Name EntityRegistrantName	ATOMERA INCORPORATED
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	30-0509586
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	750 University Avenue
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 280
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Gatos
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	95032
CY2022	dei	City Area Code CityAreaCode	(408)
CY2022	dei	Local Phone Number LocalPhoneNumber	442-5248
CY2022	dei	Security12b Title Security12bTitle	Common stock: Par value $0.001
CY2022	dei	Trading Symbol TradingSymbol	ATOM
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	209768392	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23972753	shares
CY2022	dei	Auditor Name AuditorName	Marcum llp
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, CA
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21184000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28699000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	418000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	309000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	21602000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	29008000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	158000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	196000	usd
CY2022Q4	atom	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2021Q4	atom	Longterm Prepaid Maintenance And Supplies LongtermPrepaidMaintenanceAndSupplies	91000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14000	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	14000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	700000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	900000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	4164000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	5851000	usd
CY2022Q4	us-gaap	Assets Assets	26729000	usd
CY2021Q4	us-gaap	Assets Assets	36060000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	397000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	338000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	173000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	203000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	967000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	601000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	245000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	216000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1126000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1395000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2908000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2753000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	521000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	768000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2986000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4158000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6415000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	7679000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	47500000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	47500000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23973000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23973000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23207000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23207000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	23000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	203585000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	194212000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-183295000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165854000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20314000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	28381000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26729000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36060000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	382000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	400000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	81000	usd
CY2022	us-gaap	Gross Profit GrossProfit	301000	usd
CY2021	us-gaap	Gross Profit GrossProfit	400000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10038000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8779000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6441000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6164000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1348000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	986000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	17827000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	15929000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-17526000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-15529000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	340000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	9000	usd
CY2022	us-gaap	Interest Expense InterestExpense	255000	usd
CY2021	us-gaap	Interest Expense InterestExpense	128000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	85000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-119000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17441000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15648000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	66000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17441000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-15714000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.75
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.75
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23157000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22492000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23157000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22492000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	37345000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2973000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3534000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	243000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-15714000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	28381000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3367000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	244000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5763000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17441000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	20314000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-17441000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-15714000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	77000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	67000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	200000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	186000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1229000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	532000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3367000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2973000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	108000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	177000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	59000	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	-104000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-30000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-10000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	366000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-104000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-218000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-90000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12499000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12441000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	109000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-109000	usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	5763000	usd
CY2021	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	243000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	244000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3534000	usd
CY2022	atom	Payments Of Principal For Financing Lease PaymentsOfPrincipalForFinancingLease	984000	usd
CY2021	atom	Payments Of Principal For Financing Lease PaymentsOfPrincipalForFinancingLease	470000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5023000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3307000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-7515000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-9243000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28699000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37942000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21184000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28699000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	255000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	128000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	66000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_805_eus-gaap--NatureOfOperations_z4EF9LvgXHYf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 29px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_820_zCtDTRUVyF27">NATURE OF OPERATIONS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Atomera Incorporated (“Atomera” or the “Company”) was incorporated in the state of Delaware in March 2007 under the name MEARS Technologies, Inc. and is engaged in the development, commercialization and licensing of proprietary processes and technologies for the semiconductor industry. On January 12, 2016, the Company changed its name to Atomera Incorporated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Atomera is an early-stage company, having only recently begun limited revenue-generating activities, and is devoting substantially all its efforts toward technology research and development and to commercially licensing its technology to designers and manufacturers of integrated circuits.</p>
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	21200000	usd
CY2022Q4	atom	Working Capital WorkingCapital	18700000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	50000000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zYJxiJYeY6Jl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><span id="xdx_86F_za7ThYJRsNve">Concentration of Credit Risk and Major Customers</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash, cash equivalents and accounts receivable. Two customers each represented <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zEjkwZ9dLHEg" title="Concentration of credit risk, percentage">79</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--AnotherCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zhTerO54kZw2" title="Concentration of credit risk, percentage">20</span>%,of revenue during the year ended December 31, 2022 and one customer represented <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pip0_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zC7QWsDM5yEb" title="Concentration of credit risk, percentage">100</span>% of revenue during the year ended December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">At times, the amounts on deposit at the financial institution exceed the federally insured limits. Management believes that the financial institution which holds the Company’s cash is financially sound and, accordingly, minimal credit risk exists. As of December 31, 2022 and 2021, the Company’s cash balances were in excess of insured limits maintained at the financial institution.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	6383000	usd
CY2022	atom	Remeasurement Of Rightof Use Asset And Liability In Financing Lease Obligations RemeasurementOfRightofUseAssetAndLiabilityInFinancingLeaseObligations	-458000	usd
CY2021	atom	Remeasurement Of Rightof Use Asset And Liability In Financing Lease Obligations RemeasurementOfRightofUseAssetAndLiabilityInFinancingLeaseObligations	0	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M6D
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zUDLF8R4huk8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_862_zHS2NLadubQ9">Use of estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates are used when accounting for revenue recognition, fair value of stock-based compensation and warrants, borrowing rates used for lease accounting and valuation allowance against deferred tax assets. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p>
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	382000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	400000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	382000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	400000	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3349000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3256000	shares
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	472000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	449000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	314000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	253000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	158000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	196000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation	77000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation	67000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17441000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1229000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	532000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	255000	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	128000	usd
CY2022	us-gaap	Lease Cost LeaseCost	1484000	usd
CY2021	us-gaap	Lease Cost LeaseCost	660000	usd
CY2022	atom	Fixed Lease Costs FixedLeaseCosts	248000	usd
CY2021	atom	Fixed Lease Costs FixedLeaseCosts	238000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	35000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	44000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	283000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	282000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	265000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	143000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1239000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	598000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	382000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2500000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	50000000	usd
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3000000	shares
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15648000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	66000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4500000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3367000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	2973000	usd
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	78000	usd
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	usd
CY2021	atom	Decrease In Income Tax Valuation Allowance DecreaseInIncomeTaxValuationAllowance	1800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	25309000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	23097000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2197000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1883000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	798000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	978000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1052000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	799000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	212000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	132000	usd
CY2022Q4	atom	Deferred Tax Assets Tax Deferred Lease Liability DeferredTaxAssetsTaxDeferredLeaseLiability	1079000	usd
CY2021Q4	atom	Deferred Tax Assets Tax Deferred Lease Liability DeferredTaxAssetsTaxDeferredLeaseLiability	1430000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1797000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	32444000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	28319000	usd
CY2022Q4	atom	Deferred Tax Liability Tax Right Of Use Asset DeferredTaxLiabilityTaxRightOfUseAsset	1076000	usd
CY2021Q4	atom	Deferred Tax Liability Tax Right Of Use Asset DeferredTaxLiabilityTaxRightOfUseAsset	1477000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1076000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1477000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	31368000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26842000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0351	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0277	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2595	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1141	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0070	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.0454	pure
CY2022	atom	Foreign Withholding Tax ForeignWithholdingTax	0	pure
CY2021	atom	Foreign Withholding Tax ForeignWithholdingTax	-0.0033	pure
CY2022	atom	Section382 Limitation Section382Limitation	0	pure
CY2021	atom	Section382 Limitation Section382Limitation	-0.5159	pure
CY2022	atom	Section162m Limitation Section162mLimitation	-0.0047	pure
CY2021	atom	Section162m Limitation Section162mLimitation	-0.0912	pure
CY2022	atom	Stock Based Compensation Excess Windfall StockBasedCompensationExcessWindfall	0.0120	pure
CY2021	atom	Stock Based Compensation Excess Windfall StockBasedCompensationExcessWindfall	0.2089	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0042	pure
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	896000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1070000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	480000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	151000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	306000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1046000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	896000	usd
CY2021Q4	atom	Deferred Tax Assets Valuation Allowances DeferredTaxAssetsValuationAllowances	26842000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4636000	usd
CY2022	atom	Valuation Allowance Deferred Tax Asset Change In Amount Deduction ValuationAllowanceDeferredTaxAssetChangeInAmountDeduction	110000	usd
CY2022Q4	atom	Deferred Tax Assets Valuation Allowances DeferredTaxAssetsValuationAllowances	31368000	usd
CY2020Q4	atom	Deferred Tax Assets Valuation Allowances DeferredTaxAssetsValuationAllowances	28627000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6125000	usd
CY2021	atom	Valuation Allowance Deferred Tax Asset Change In Amount Deduction ValuationAllowanceDeferredTaxAssetChangeInAmountDeduction	7910000	usd
CY2021Q4	atom	Deferred Tax Assets Valuation Allowances DeferredTaxAssetsValuationAllowances	26842000	usd

Files In Submission

Name	View Source	Status
atom-20221231_cal.xml	Edgar Link	unprocessable
atom-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
atom-20221231_pre.xml	Edgar Link	unprocessable
0001683168-23-000938-index-headers.html	Edgar Link	pending
0001683168-23-000938-index.html	Edgar Link	pending
0001683168-23-000938.txt	Edgar Link	pending
0001683168-23-000938-xbrl.zip	Edgar Link	pending
a1.jpg	Edgar Link	pending
atom-20221231.xsd	Edgar Link	pending
atomera_ex2301.htm	Edgar Link	pending
atomera_ex3101.htm	Edgar Link	pending
atomera_ex3102.htm	Edgar Link	pending
atomera_ex3201.htm	Edgar Link	pending
atomera_i10k-123122.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
atom-20221231_def.xml	Edgar Link	unprocessable
atomera_i10k-123122_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ATOM
Atomera Inc Stock $atom

2023 Q1 Form 10-K Financial Statement

#000168316823000938 Filed on February 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOM Atomera Inc Stock $atom

2023 Q1 Form 10-K Financial Statement

#000168316823000938 Filed on February 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ATOM
Atomera Inc Stock $atom